Pyrroloquinoline Quinone
CAS 72909-34-3
Pyrroloquinoline Quinone (CAS 72909-34-3) is a pharmaceutical compound with 3 bioactivity targets and 3 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 17950.5 nM | 4 | - |
| - | EC50 | 71 nM | 1 | - |
| - | Ki | 332 nM | 1 | - |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Pyrroloquinoline Quinone used for in pharmaceutical contexts?
Pyrroloquinoline Quinone (CAS 72909-34-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Pyrroloquinoline Quinone?
Pyrroloquinoline Quinone has 3 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Cognitive disorder, Idiopathic urticaria, Rash erythematous. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Pyrroloquinoline Quinone also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Pyrroloquinoline Quinone (PQQ) with EU status "permitted".
What clinical phase is Pyrroloquinoline Quinone in?
No phase 1-4 clinical development badge is rendered for Pyrroloquinoline Quinone because the matched compound identifier rows do not contain a max-phase value.